Search results
Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 6 days agoBiogen (NASDAQ:BIIB) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0%...
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 7 days agoIt's been a good week for Biogen Inc. (NASDAQ:BIIB) shareholders, because the company has just...
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 5 days agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, ...
FY2024 Earnings Forecast for Biogen Inc. (NASDAQ:BIIB) Issued By Cantor Fitzgerald
ETF DAILY NEWS· 4 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at Cantor Fitzgerald lifted their FY2024 earnings per share (EPS) estimates for Biogen in a research note issued ...
Biogen (BIIB)'s Market Evaluation: A Fair Valuation Analysis
Guru Focus· 5 days agoBiogen Inc (BIIB, Financial) has recently experienced a daily gain of 4.43%, but this contrasts with a three-month loss of -12.67%. This article aims to delve into the valuation ...
The Analyst Landscape: 27 Takes On Biogen - Biogen (NASDAQ:BIIB)
Benzinga· 5 days agoLoading... Loading... In the preceding three months, 27 analysts have released ratings for Biogen BIIB , presenting a wide array of perspectives from bullish to bearish. The ...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 3 days agoUtilizing one-week price change and the monthly percentage change in earnings estimates, among other...
William Blair Weighs in on Biogen Inc.’s Q3 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair upped their Q3 2024 earnings per share (EPS) estimates for shares of Biogen in a report issued ...
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Zacks via Yahoo Finance· 24 hours agoOver the past six months, shares of MRNA have risen 46.27%. (See the last biotech stock roundup...
This midcap stock is rallying 16% after posting earnings and we told you to buy it By Investing.com
Investing.com· 22 hours agoAlso part of our list of picks for May, Apple (NASDAQ:AAPL) stock jumped 7% in post-market trading...